1. Emrich, H.M. (1982). Prophylactic therapies in affective disorders: mode of action from a clinical point of view. In: Emrich, H.M., Aldenhoff, J.B. and Lux, H.D. (eds). Basic Mechanisms in the Action of Lithium. pp. 202–14. (Amsterdam: Excerpta Medica)
2. Angst, J. and Grof, P.(1979). Selection of patients with recurrent affective illness for a long term study: testing research criteria on prospective follow-up data. In: Cooper, T.B., Gershon, S., Kline, N.S. and Schou, M. (eds). Lithium: Controversies and Unresolved Issues. pp. 355–69. (Amsterdam: Excerpta Medica)
3. Grof, P., Angst, J., Karasek, M. and Keitner, G. (1979). Selection of an individual patient for long term lithium treatment in clinical practice. In: Cooper, T.B., Gershon, S., Kline, N.S. and Schou, M. (eds). Lithiurn:Controversies and Unresolved Issues. pp. 370–80. (Amsterdam: Excerpta Medica)
4. Cazzullo, C.L., Smeraldi, E., Sacchetti, E. and Bottinelli, S. (1975). Intracellular lithium concentration and clinical response. Brit. J. Psychiat., 126, 298–300.
5. Sacchetti, E., Bottinelli, S., Bellodi, L. et al. (1977). Erythrocyte/plasma lithium ratios. Lancet. i, 908.